Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014
October 20, 2014 at 07:35 AM EDT
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that results from a ...